A breakthrough in cell therapy of solid tumor by Zhifei biological joint stock company
The first indication clinical trial of c-4-29 cell preparation developed by Chongqing precision Biotechnology Co., Ltd. (precision Biology) was approved by the drug evaluation center of State Drug Administration on December 10, 2020, and the second indication clinical trial application was accepted by CDE on July 8, 2021, realizing the breakthrough of car-t cell therapy for solid tumor. The company's CD70 target is the first in China, and the product c-4-29 cell preparation under research is used for the treatment of patients with relapsed / refractory multiple myeloma or advanced / metastatic renal cell carcinoma aged 18 years or above.
This text is a result of machine translation.
Related companies：
Briefing Jun 20, 2022 04:54 PM
· Technology
The official results of the French parliamentary elections were announced, and the ruling party coalition held a relatively large number of seats
Briefing May 19, 2022 05:45 PM
· Healthcare
Shenzhen textile A: the order of line 7 is full, and the production line speed is climbing
In-depth
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 18, 2022 06:30 PM
Briefing Mar 15, 2022 12:19 PM
Half day main capital net inflow of power equipment, non bank finance, selling banks, etc
Insight
Healthcare
Pulnovo Medical: Chinese Medical Device Companies are Making Their Voices Heard Globally
‘Chinese medical device companies, represented by Pulnovo Medical, have always pursued medical innovation under the support of policies and capital. They have increasingly improved their technical innovation, strategic planning, and product competitiveness. Navigating the way through a dynamic, ever-changing market, Chinese medical device companies are making their voices heard in the global market.’
Feb 25, 2023 09:29 AM
Briefing Aug 03, 2021 11:10 AM
· Healthcare
Monitoring of main funds of star mine: Top 10 list of early trading
Briefing Jul 23, 2021 10:13 AM
· Healthcare
Pharmaceutical and biological stocks fell sharply in early trading
Briefing Jul 20, 2021 10:05 PM
US Senate committee to investigate the role of cryptocurrency in cyber crime
Briefing Jul 07, 2021 03:24 PM
· Healthcare
The first bank of China fund to release its second Quarterly Report
See more
Read next
Insight
In-depth
Insight
In-depth
Insight
In-depth
Insight
In-depth